Casaril Andrea, Inama Marco, Impellizzeri Harmony, Bacchion Matilde, Creciun Mihail, Moretto Gianluigi
Endocrine Surgery Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
Gland Surg. 2020 Jan;9(Suppl 1):S54-S60. doi: 10.21037/gs.2019.12.14.
Differentiated thyroid cancers are the most common malignancies arising in thyroid gland. Papillary thyroid cancer presents a very favorable prognosis, while follicular type is slightly more aggressive, mainly for its attitude to hematogenous spreading with distant metastases. Papillary microcarcinoma (10 mm or less) has an excellent prognosis, largely demonstrated, and its management is changed in the last few years, reducing surgical procedure, role of radio iodine ablation (RAI) and TSH suppression. But no effective data are available for follicular thyroid microcarcinoma (mFTC); very few reports and studies are present in literature about mFTC, mainly for its low incidence. Aim of this paper is to review current literature to reach, in absence of evidence, some suggestion in managing mFTC.
分化型甲状腺癌是甲状腺最常见的恶性肿瘤。甲状腺乳头状癌预后非常良好，而滤泡型则稍具侵袭性，主要因其易于血行播散并发生远处转移。甲状腺微小癌（直径10毫米或更小）预后极佳，这已得到充分证实，并且在过去几年中其治疗方式有所改变，减少了手术操作、放射性碘消融（RAI）及促甲状腺激素抑制的作用。但对于滤泡状甲状腺微小癌（mFTC）尚无有效数据；关于mFTC的文献报道和研究非常少，主要是因为其发病率低。本文的目的是回顾当前文献，在缺乏证据的情况下，对mFTC的治疗提出一些建议。
